Comparison of safety and efficacy of fluorouracil + oxaliplatin + irinotecan (FOLFOXIRI) and modified FOLFOXIRI with bevacizumab for metastatic colorectal cancer: data from clinical practice
Sign Up to like & getrecommendations! Published in 2021 at "International Journal of Colorectal Disease"
DOI: 10.1007/s00384-021-04064-9
Abstract: The efficacy of fluorouracil + oxaliplatin + irinotecan with bevacizumab (FOLFOXIRI + BV) has been verified for metastatic colorectal cancer (mCRC). In clinical practice, the original (O-FOLFOXIRI + BV) and modified dose settings (M-FOLFOXIRI + BV) are adopted for Asian patients. We aimed to compare… read more here.
Keywords: safety; group; efficacy; cancer ... See more keywords
Association between poorly differentiated clusters and efficacy of 5-fluorouracil-based adjuvant chemotherapy in stage III colorectal cancer
Sign Up to like & getrecommendations! Published in 2017 at "Japanese Journal of Clinical Oncology"
DOI: 10.1093/jjco/hyw209
Abstract: Abstract The efficacy of 5-fluorouracil-based adjuvant chemotherapy differs according to poorly differentiated cluster grade in colorectal cancer. Poorly differentiated cluster may have an important role in determining the most suitable treatment strategy. read more here.
Keywords: based adjuvant; poorly differentiated; adjuvant chemotherapy; colorectal cancer ... See more keywords